Spots Global Cancer Trial Database for Innovative "Scoring System" in Breast Cancer Post Neoadiuvant Chemotherapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Innovative "Scoring System" in Breast Cancer Post Neoadiuvant Chemotherapy
Official Title: Innovative "Scoring System" in Breast Cancer: a Valid Surgical Choice After Neoadjuvant Chemotherapy
Study ID: NCT05213403
Conditions
Interventions
Study Description
Brief Summary: Our aim is to create a Scoring System (SS) able of guaranteeing radical oncology by completely removing cancer and aesthetic outcomes in line with the needs or expectations of the patients that helps surgeons to decide the type of surgery in patients undergoing NACT. Secondary outcome is to assess the ability of the score to avoid neoplastic relapses by evaluating: * Loco-regional disease free-survival (LR-DFS): months between start of NACT and date of a neoplastic recurrence in residual mammary gland, in ipsilateral chest wall or in ipsilateral axilla. * Distant disease-free survival (DDFS): months between start of NACT and date of onset of visceral or skeletal metastases. * Overall survival (OS): months from the start of NACT to death or last follow-up.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Contact Details
Name: Gianluca Franceschini, Prof.
Affiliation: IRCCS Policlinico Agostino Gemelli - Roma
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
